Singular Genomics Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep '21 Sep 30, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Net Income	-0.37	-3.96	-17.63	-15.7	-5.86	-1.23
Depreciation & Amortization	0.61	0.69	1.32	0.18	0.07	0.04
Loss (Gain) From Sale of Assets	-1.68	-1.68	-	-	-	-
Asset Writedown & Restructuring Costs	1.99	1.99	9.38	-	-	-
Loss (Gain) From Sale of Investments	-	-	1	0.01	-	-
Loss (Gain) on Equity Investments	-	-	0.11	0.99	-	-
Stock-Based Compensation	0.04	0.77	3.12	5.31	4.54	0.17
Other Operating Activities	1.06	1.27	0.22	5.8	0.13	0.02
Change in Accounts Receivable	1.53	-0.03	0.31	-0.42	-0.02	0
Change in Inventory	5.08	0.01	0.11	0.13	-0.15	-0.08
Change in Accounts Payable	-11.42	-0.3	-0.19	1.92	-0.15	0.34
Change in Other Net Operating Assets	3.37	0.94	0.07	-0	0	0.04
Operating Cash Flow	0.21	-0.3	-2.18	-1.78	-1.45	-0.7
Capital Expenditures	-0.01	-0.01	-0.25	-0.3	-0.3	-
Cash Acquisitions	-	-	-	0.82	-	-
Sale (Purchase) of Intangibles	-	-	-	-0.15	-	-
Investing Cash Flow	-0.01	-0.01	-0.25	0.37	-0.3	-
Short-Term Debt Issued	-	-	-	0.24	1.81	0.67
Long-Term Debt Issued	-	0.52	-	-	-	-
Total Debt Issued	0.01	0.52	-	0.24	1.81	0.67
Short-Term Debt Repaid	-	-	-	-	-0.15	-
Long-Term Debt Repaid	-	-0.24	-0.33	-	-	-
Total Debt Repaid	-0.2	-0.24	-0.33	-	-0.15	-
Net Debt Issued (Repaid)	-0.19	0.28	-0.33	0.24	1.66	0.67
Issuance of Common Stock	-	0.13	1.33	2.49	-	-
Other Financing Activities	-0.03	-	-	-	0.1	0.03
Financing Cash Flow	-0.93	0.41	1	2.73	1.76	0.7
Foreign Exchange Rate Adjustments	-0.15	-0.06	0.02	0.14	-	-
Net Cash Flow	-0.88	0.04	-1.4	1.44	0.01	0.01
Free Cash Flow	0.21	-0.31	-2.43	-2.09	-1.75	-0.7
Free Cash Flow Margin	10.61%	-6.72%	-45.24%	-284.82%	-443.41%	-144.77%
Free Cash Flow Per Share	0.00	-0.01	-0.06	-0.15	-0.29	-0.28
Levered Free Cash Flow	-1.1	0.45	0.25	4.67	1.02	-
Unlevered Free Cash Flow	-0.98	0.58	0.38	4.67	1.18	-
Change in Net Working Capital	1.71	-0.56	-0.53	-0.45	-0.39	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q